CF Foundation | Research Overview Path to a Cure

36
Published on februari 5, 2021 by

In 2019, we launched the Path to a Cure which centers around three core strategies to address the underlying cause of cystic fibrosis: repairing broken CFTR protein, restoring CFTR protein when none exists, and fixing the underlying genetic mutation to address the root cause of CF.

Watch our Path to a Cure research webinar to hear from Bill Skach, MD, EVP and chief medical officer, and JP Clancy, MD, VP of clinical research, discuss updates on the research underway to accelerate treatments, what the future holds, and more.

Originally recorded February 4, 2021.

Category

Add your comment

Your email address will not be published.